Personal Utility and Genomic Information: Look Before You Leap

Overview

Journal Genet Med

Publisher Elsevier

Specialty Genetics

Date 2009 Jul 23

PMID 19623080

Citations 39

Authors

Scott D Grosse

Colleen M McBride

James P Evans

Muin J Khoury

Affiliations

Soon will be listed here.

Citing Articles

The Diagnostic Landscape of Adult Neurogenetic Disorders.

Waung M, Ma F, Wheeler A, Zai C, So J Biology (Basel). 2023; 12(12).

PMID: 38132285 PMC: 10740572. DOI: 10.3390/biology12121459.

Determining the utility of diagnostic genomics: a conceptual framework.

Mallett A, Stark Z, Fehlberg Z, Best S, Goranitis I Hum Genomics. 2023; 17(1):75.

PMID: 37587497 PMC: 10433656. DOI: 10.1186/s40246-023-00524-1.

Perceived utility and disutility of genomic sequencing for pediatric patients: Perspectives from parents with diverse sociodemographic characteristics.

Halley M, Young J, Fernandez L, Kohler J, Bernstein J, Wheeler M Am J Med Genet A. 2022; 188(4):1088-1101.

PMID: 34981646 PMC: 8923971. DOI: 10.1002/ajmg.a.62619.

Conceptualization of utility in translational clinical genomics research.

Smith H, Brothers K, Knight S, Ackerman S, Rini C, Veenstra D Am J Hum Genet. 2021; 108(11):2027-2036.

PMID: 34687653 PMC: 8595895. DOI: 10.1016/j.ajhg.2021.08.013.

Conceptualising 'Benefits Beyond Health' in the Context of the Quality-Adjusted Life-Year: A Critical Interpretive Synthesis.

Engel L, Bryan S, Whitehurst D Pharmacoeconomics. 2021; 39(12):1383-1395.

PMID: 34423386 DOI: 10.1007/s40273-021-01074-x.

References

Rogowski W . Genetic screening by DNA technology: a systematic review of health economic evidence. Int J Technol Assess Health Care. 2006; 22(3):327-37. DOI: 10.1017/s0266462306051221. View

Foster M, Mulvihill J, Sharp R . Evaluating the utility of personal genomic information. Genet Med. 2009; 11(8):570-4. DOI: 10.1097/GIM.0b013e3181a2743e. View

Chao S, Roberts J, Marteau T, Silliman R, Cupples L, Green R . Health behavior changes after genetic risk assessment for Alzheimer disease: The REVEAL Study. Alzheimer Dis Assoc Disord. 2008; 22(1):94-7. PMC: 2483341. DOI: 10.1097/WAD.0b013e31815a9dcc. View

Saban K, Stroupe K, Bryant F, Reda D, Browning M, Hynes D . Comparison of health-related quality of life measures for chronic renal failure: quality of well-being scale, short-form-6D, and the kidney disease quality of life instrument. Qual Life Res. 2008; 17(8):1103-15. DOI: 10.1007/s11136-008-9387-5. View

Carlson J, Henrikson N, Veenstra D, Ramsey S . Economic analyses of human genetics services: a systematic review. Genet Med. 2005; 7(8):519-23. DOI: 10.1097/01.gim.0000182467.79495.e2. View

Green R, Roberts J, Cupples L, Relkin N, Whitehouse P, Brown T . Disclosure of APOE genotype for risk of Alzheimer's disease. N Engl J Med. 2009; 361(3):245-54. PMC: 2778270. DOI: 10.1056/NEJMoa0809578. View

Regier D, Friedman J, Makela N, Ryan M, Marra C . Valuing the benefit of diagnostic testing for genetic causes of idiopathic developmental disability: willingness to pay from families of affected children. Clin Genet. 2009; 75(6):514-21. DOI: 10.1111/j.1399-0004.2009.01193.x. View

Watson V, Ryan M . Exploring preference anomalies in double bounded contingent valuation. J Health Econ. 2006; 26(3):463-82. DOI: 10.1016/j.jhealeco.2006.10.009. View

Constantinescu F, Goucher S, Weinstein A, Smith W, Fraenkel L . Understanding why rheumatoid arthritis patient treatment preferences differ by race. Arthritis Rheum. 2009; 61(4):413-8. PMC: 4062353. DOI: 10.1002/art.24338. View

10.

Khoury M, McBride C, Schully S, Ioannidis J, Gregory Feero W, Janssens A . The Scientific Foundation for personal genomics: recommendations from a National Institutes of Health-Centers for Disease Control and Prevention multidisciplinary workshop. Genet Med. 2009; 11(8):559-67. PMC: 2936269. DOI: 10.1097/GIM.0b013e3181b13a6c. View

11.

Grosse S, Khoury M . What is the clinical utility of genetic testing?. Genet Med. 2006; 8(7):448-50. DOI: 10.1097/01.gim.0000227935.26763.c6. View

12.

Wordsworth S, Ryan M, Skatun D, Waugh N . Women's preferences for cervical cancer screening: a study using a discrete choice experiment. Int J Technol Assess Health Care. 2006; 22(3):344-50. DOI: 10.1017/s0266462306051245. View

13.

Grosse S, Wordsworth S, Payne K . Economic methods for valuing the outcomes of genetic testing: beyond cost-effectiveness analysis. Genet Med. 2008; 10(9):648-54. DOI: 10.1097/gim.0b013e3181837217. View

14.

Cappelli M, Surh L, Humphreys L, Verma S, Logan D, Hunter A . Measuring women's preferences for breast cancer treatments and BRCA1/BRCA2 testing. Qual Life Res. 2002; 10(7):595-607. DOI: 10.1023/a:1013123915272. View

15.

Saam J, Gudgeon J, Aston E, Brothman A . How physicians use array comparative genomic hybridization results to guide patient management in children with developmental delay. Genet Med. 2008; 10(3):181-6. DOI: 10.1097/GIM.0b013e3181634eca. View

16.

Phillips K, Reed Johnson F, Maddala T . Measuring what people value: a comparison of "attitude" and "preference" surveys. Health Serv Res. 2003; 37(6):1659-79. PMC: 1464045. DOI: 10.1111/1475-6773.01116. View

17.

Iredale R, Rapport F, Sivell S, Jones W, Edwards A, Gray J . Exploring the requirements for a decision aid on familial breast cancer in the UK context: a qualitative study with patients referred to a cancer genetics service. J Eval Clin Pract. 2008; 14(1):110-5. DOI: 10.1111/j.1365-2753.2007.00811.x. View